Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Child Neurology
What is your approach to management in severe COVID19-associated myositis?
Related Questions
Does persistent focal slowing without epileptiform discharges indicate increased seizure risk in patients without significant structural abnormalities?
Would you use bupropion for mood disorder or substance use in an adult patient with previous childhood seizures that resolved?
Are there specific tools that you request for an IEP of a child with dyslexia?
What is your approach to dosing phenobarbital for a neonate on intermittent hemodialysis?
What are your preferred anti-seizure medications in Doose syndrome?
What pharmacological management to you consider in patients with Autism Spectrum Disorder whose primary behavior is aggression?
When do you consider testing with stroke gene panels in young stroke patients?
When, if ever, would you pursue genetic testing in an asymptomatic child with multiple first-degree relatives with epilepsy?
Is there utility to ordering biochemical screening labs for global developmental delay?
How do different inflammatory markers like CRP and ferritin contribute differently, if at all, to the monitoring of CART neurotoxicity?
